IVETh: First Industrial Integrator in Biotherapy and Bioproduction
IVETh is the first platform dedicated to the engineering and characterization of extracellular vesicles and nanovectors for therapeutic and diagnostic applications. It has been accredited under the France 2030 program and is part of the Réseau des intégrateurs en Bioproduction et Biothérapie (RIBB).
Our Mission
The IVETh integrator aims to accelerate technological maturation—from the research laboratory to the patient’s bedside—of healthcare innovations based on extracellular vesicles and nanovectors for therapeutic and diagnostic purposes.
How? Our experts develop innovative methodologies and training programs specifically designed to address the scientific, technical, and regulatory requirements of your R&D projects involving extracellular vesicles and nanovectors.
Follow us on social media
Our partners
News
Inserm Workshop 273 – Advances in therapeutic applications of extracellular vesicles
We are co-organizing an INSERM Workshop on Advances in therapeutic applications of extracellular vesicles. First part (theoretical) will take place in Bordeaux in June. Second part (technical) will take place within IVETh in Paris in October. Deadline for registration...